Process Monitoring in Pharma Manufacturing on October 27-29, 2026 in Boston, United States

The process monitoring market is set to grow from $5.51 billion to $13.30 billion by 2032.

With regulators raising expectations around in-process controls, real-time monitoring, and lifecycle verification, and biopharma organizations increasing investment in PAT, manufacturing intelligence, and advanced analytics; process monitoring has become a critical strategic priority. At the same time, expanding biologics pipelines and advanced modalities are increasing complexity. Global manufacturing networks are placing additional pressure on teams to maximize yield, ensure consistency, and improve operational efficiency without increasing risk. In today’s environment, the challenge is no longer collecting data, but turning it into faster, more confident and impactful decisions across the product lifecycle.

The 5th Process Monitoring in Pharma Manufacturing Summit (formerly the PAT and Real Time Quality Summit) is where industry leaders come to turn ambition into execution. Designed for pharma, biotech, and CDMO teams driving process performance, the meeting focuses on shifting from fragmented tools to integrated, end-to-end monitoring strategies that deliver real business impact. Discover how leading organizations are transforming real-time data into predictive insight, enabling faster decision-making, reducing batch risk, and unlocking higher yield and efficiency.

Join 60+ global experts united by a common goal: positioning process monitoring as a core driver of manufacturing excellence and competitive advantage.

URLs:

Tickets: https://go.evvnt.com/3677005-2?pid=10008

Brochure: https://go.evvnt.com/3677005-3?pid=10008

Time: 8:30 AM - 2:15 PM

Prices:

Pharma, Biotech, CMO AND CDMO Pricing - 2 Day Pass (Conference Only): USD 2699.00,

Pharma, Biotech, CMO AND CDMO Pricing - 3 Day Pass (Conference + 1 Workshop): USD 3148.00,

Pharma, Biotech, CMO AND CDMO Pricing - 3 Day Pass (Conference + 2 Workshops): USD 3597.00,

Service and Solution Provider Pricing - 2 Day Pass (Conference Only): USD 3799.00,

Service and Solution Provider Pricing - 3 Day Pass (Conference + 1 Workshop): USD 4548.00,

Service and Solution Provider Pricing - 3 Day Pass (Conference + 2 Workshops): USD 5297.00

Speakers: Ryan George, Senior Scientist - CMC Technical Operations, Astellas Gene Therapies, Loleta Chung, Senior Associate Director - Manufacturing Science and Technology West Train and Cleaning Validation, Boehringer Ingelheim, Chadakarn Sirasitthichoke, Manager Senior Process Engineer, Bristol Myers Squibb, Scott Carpenter, Senior Director - Process Analytical Technology and Quality Control Operations, Eli Lilly and Co., Samira Beyramysoltan, Senior Scientist - Simulation and Modeling, GlaxoSmithKline, Hanzhou Feng, Associate Principal Scientist, Merck and Co, Akshay Phulgirkar, Senior Manager, Manufacturing Sciences and Technology INT, Moderna, Joshua Kulakofsky, Associate Director, Formulation Development, Noven Pharmaceuticals, Andreas Kunov-Kruse, Analytical Science Specialist, Novo Nordisk, Nii Odoi Oddoye, Senior Manager - Manufacturing Science and Technology, Pfizer, Aaron Cowley, Chief Scientific Officer, ReciBioPharm, Edita Botonjic-Sehic, Head of Process Analytical Technology and Data Science, ReciBioPharm, Lorenz Liesum, Head of Advanced Analytical Technologies, Roche, Ramila Peiris, Global Head of Data Management, Machine Learning, Artificial Intelligence Platform, Manufacturing Science and Technology, Sanofi, Luc Nguyen, Global Head PAT and Advanced Process Controls - Practices Excellence and Innovation - MSAT, Sanofi, Muthu Meiyappan, Head of Technology Development and Implementation, Takeda Pharmaceutical, Jan Panteli, Director, Upstream Process Development, Gene Therapy, Ultragenyx Pharmaceutical Inc.